STRATA Skin Sciences (NASDAQ:SSKN) Earns Buy Rating from Analysts at Maxim Group

Maxim Group began coverage on shares of STRATA Skin Sciences (NASDAQ:SSKN) in a report issued on Thursday morning,Benzinga reports. The firm issued a buy rating and a $6.00 price objective on the medical device company’s stock.

STRATA Skin Sciences Price Performance

Shares of NASDAQ SSKN opened at $2.64 on Thursday. STRATA Skin Sciences has a twelve month low of $2.51 and a twelve month high of $6.00. The stock’s 50 day moving average price is $2.87 and its 200-day moving average price is $2.97. The company has a market capitalization of $11.01 million, a PE ratio of -0.99 and a beta of 1.33. The company has a quick ratio of 0.94, a current ratio of 1.13 and a debt-to-equity ratio of 1.62.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.